Literature DB >> 699482

Distinctive patterns of amobarbital metabolites.

W Kalow, B K Tang, D Kadar, T Inaba.   

Abstract

This paper establishes that the relative proportion of amobarbital metabolites in urine is highly variable from person to person and that observations of plasma half-life give no indication of this variability, but it shows that a valid estimate of a given person's metabolite pattern can be obtained by studying a single urine specimen in the postdistributive phase. The two metabolites which were measured in urine accounted on the average of 9 subjects for 80% +/- 3% of the dose with a range from 66% to 94%. The two metabolites were the well known 3'-hydroxyamobarbital (COH) as a product of side chain hydroxylation and N-beta-D-glucopyranosyl amobarbital (N-glu), a glucose conjugate which at some earlier time had been mistaken for an N-hydroxylation product. Among 129 volunteer subjects, the metabolite ratio N-glu/COH showed a median value of about 0.5 with a range from 0 to 2.8. A virtual absence of N-glu was observed in one of the 129 subjects and confirmed by a second administration of amobarbital 3 mo later. Of the 14 subjects with predominant N-glu excretion 4 were of Chinese origin, while there were 6 Chinese among the 115 other subjects (p less than 0.02).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 699482     DOI: 10.1002/cpt1978245576

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

1.  Stereochemical characterization of the diastereomers of the amobarbital N-glucosides excreted in human urine.

Authors:  W H Soine; P J Soine; F C Wireko; D J Abraham
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

Review 3.  Assessment of the drug metabolism capacity of the liver.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

Review 4.  Molecular genetics of cytochrome P450 IID. Anomalies of drug metabolism.

Authors:  E Jacqz-Aigrain; S Panserat; L Sica; R Krishnamoorthy
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

5.  An assessment of short-cut procedures for studying drug metabolism in vivo using amobarbital as a model drug.

Authors:  B K Tang; W Kalow; L Endrenyi; F Y Chan
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Multidose studies in the human metabolism of pentobarbitone.

Authors:  W C Baldeo; J N Gilbert; J W Powell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

7.  Human pharmacogenomics: the development of a science.

Authors:  Werner Kalow
Journal:  Hum Genomics       Date:  2004-08       Impact factor: 4.639

8.  Phenobarbital N-glucosylation by human liver microsomes.

Authors:  Sheela G Paibir; William H Soine; Diana F Thomas; Robert A Fisher
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jan-Mar       Impact factor: 2.441

9.  The fate of phenobarbitone in children in hypothermia and at normal body temperature.

Authors:  D Kadar; B K Tang; A W Conn
Journal:  Can Anaesth Soc J       Date:  1982-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.